Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BREF
May 14, 2001
- Japan-EU Mutual GMP Recognition Accord to Be Approved by Diet
May 14, 2001
- 6 New Drugs Including Insulin-lyspro Approved
May 14, 2001
- Chugai Starts V's 21 Plan: President Nagayama
May 14, 2001
- PMSB Proposes NDA Dossier Guide According to CTD
May 14, 2001
- Yamanouchi to Boost Sales to\600 Bil. in FY2005: President Takenaka
May 14, 2001
- REGULATORY NEWS IN BRIEF -1-
May 14, 2001
- Hitachi to Develop New Clinical Data Management System with AstraZeneca
May 14, 2001
- REGULATORY NEWS IN BRIEF -2-
May 14, 2001
- FTC Inspects Tohoku Wholesalers on Suspicion of Price Cartel
May 14, 2001
- Kenporen Predicts 6.6% Increase in Medical Costs for Elderly
May 14, 2001
- JPMA to Prepare for ICH6 in Japan in 2003
May 14, 2001
- 10 Kinds of Advanced Medical Treatment Services Approved
May 14, 2001
- JPMA to Hold Int'l Panel Focusing on Patient-Oriented Healthcare
May 14, 2001
- Evidence on Acute Myocardial Infarctions in Japan Compiled by Korosho Study Group
May 14, 2001
- Wholesalers' FTC to Stop Members Supporting Medical Institution Social Gatherings
May 14, 2001
- Diagnostic, Treatment GL for Urinary Incontinence in Women Prepared
May 14, 2001
- BUSINESS NEWS IN BRIEF -2-
May 14, 2001
- Health Insurance Coverage for Viagra Demanded by the Public: Pfizer Seminar
May 14, 2001
- Kyowa Hakko Kogyo Aims at \300 Bil. Drug Sales in 2011: President Hirata
May 14, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…